BillionToOne, Inc. (BLLN) Stock Analysis and Metrics

Sector: Healthcare Industry: Diagnostics & Research CIK: 0002070849

Market Cap 883.77 Mn

P/B -3.69

P/E -21.26

P/S 5.79

ROIC (Qtr) 0.00

Div Yield % 0.00

Rev 1y % (Qtr) 117.40

Total Debt (Qtr) 108.14 Mn

Debt/Equity (Qtr) -0.45

About

Healthy cash reserves of 195.15M provide 34.56x coverage of short-term debt 5.65M, demonstrating strong liquidity position and minimal refinancing risk.
Strong tangible asset base of 327.52M provides 3.03x coverage of total debt 108.14M, indicating robust asset backing and low credit risk.
Tangible assets of 327.52M provide exceptional 122.07x coverage of deferred revenue 2.68M, showing strong service capability backing.
Tangible assets of 327.52M provide robust 11.98x coverage of other current liabilities 27.33M, indicating strong asset backing.
Retained earnings of (280.72M) represent substantial 1.17x of equity (239.51M), indicating strong internal capital generation.

Operating cash flow of 0 provides insufficient coverage of deferred revenue obligations of 2.68M, which is 0x, raising concerns about future service delivery capabilities.
Tangible assets of 327.52M provide limited backing for working capital of 210.93M, which is 1.55x, suggesting increased operational risk in market downturns.
Other non-current assets of 9.11M provide minimal coverage for long-term debt of 102.49M, which is 0.09x, indicating potential asset-liability mismatch.

Companies in the Diagnostics & Research

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	TMO	Thermo Fisher Scientific Inc.	229.80 Bn	34.98	5.25	35.68 Bn
2	DHR	Danaher Corp /De/	168.69 Bn	48.16	6.95	16.86 Bn
3	IDXX	Idexx Laboratories Inc /De	57.54 Bn	56.01	13.81	1.09 Bn
4	IQV	Iqvia Holdings Inc.	42.51 Bn	33.13	2.67	15.19 Bn
5	A	Agilent Technologies, Inc.	41.38 Bn	31.76	5.96	3.35 Bn
6	NTRA	Natera, Inc.	32.34 Bn	-104.61	15.28	0.18 Bn
7	MTD	Mettler Toledo International Inc/	30.48 Bn	36.47	7.73	2.21 Bn
8	WAT	Waters Corp /De/	23.59 Bn	36.36	7.60	1.49 Bn

Current Valuation	Value	Ind Avg
EV to Assets EV to Assets	0.00	2.83
EV to Cash from Ops. EV to Cash from Ops.	0.00	19.40
EV to Debt EV to Debt	0.00	55.09
EV to EBIT EV to EBIT	0.00	19.01
EV to EBITDA EV to EBITDA	0.00	4.60
EV to Free Cash Flow [EV/FCF] EV to Free Cash Flow [EV/FCF]	0.00	-2.36
EV to Market Cap EV to Market Cap	0.00	1.57
EV to Revenue EV to Revenue	0.00	5.06
Price to Book Value [P/B] P/B	-3.69	1.40
Price to Earnings [P/E] P/E	-21.26	19.36

Dividend Metrics	Value	Ind Avg	Percentile
Dividend Coverage Ratio Div Coverage (Qtr)	0.00	-2.00
Dividend Payout Ratio % Div Payout % (Qtr)	0.00	2.86
Dividend per Basic Share Div per Share (Qtr)	0.00	0.19
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr)	0.00	1.94
Interest Coverage Int. cover (Qtr)	0.00	-129.02

Growth Metrics	Value	Ind Avg	Percentile
Capex Growth (1y) % Capex 1y % (Qtr)	0.00	-35.01
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr)	0.00	24.08
Dividend Growth (1y) % Dividend Growth (1y) %	0.00	0.25
EBIAT Growth (1y) % EBIAT 1y % (Qtr)	0.00	-55.31
EBITDA Growth (1y) % EBITDA 1y % (Qtr)	0.00	-457.27
EBIT Growth (1y) % EBIT 1y % (Qtr)	0.00	-42.01
EBT Growth (1y) % EBT 1y % (Qtr)	0.00	-72.92
EPS Growth (1y) % EPS 1y % (Qtr)	0.00	-70.88
FCF Growth (1y) % FCF 1y % (Qtr)	0.00	56.94
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr)	0.00	185.76

Liquidity Ratios	Value	Ind Avg
Asset Utilization Ratio Asset Util Ratio (Qtr)	0.00	0.57
Cash Payout Ratio Cash Payout (Qtr)	0.00	0.01
Cash Ratio Cash Ratio (Qtr)	4.78	1.23
Current Ratio Curr Ratio (Qtr)	6.17	2.69
Debt to Equity Ratio Debt/Equity (Qtr)	-0.45	-0.84
Interest Cover Ratio Int Coverage (Qtr)	0.00	-129.02
Times Interest Earned Times Interest Earned (Qtr)	0.00	-129.02

Profitability	Value	Ind Avg	Percentile
EBITDA Margin % EBITDA Margin % (Qtr)	0.00	-98.25
EBIT Margin % EBIT Margin % (Qtr)	0.00	-116.67
EBT Margin % EBT Margin % (Qtr)	0.00	-115.28
Gross Margin % Gross Margin % (Qtr)	0.00	44.77
Net Profit Margin % Net Margin % (Qtr)	0.00	-114.12